Literature DB >> 19004950

A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome.

David J Heslin1, Pablo Murcia, Frederick Arnaud, Koenraad Van Doorslaer, Massimo Palmarini, Jack Lenz.   

Abstract

Human endogenous retrovirus K (HERV-K) is the most intact retrovirus in the human genome. However, no single HERV-K provirus in the human genome today appears to be infectious. Since the Gag protein is the central component for the production of retrovirus particles, we investigated the abilities of Gag from two HERV-K proviruses to support production of virus-like particles and viral infectivity. HERV-K113 has full-length open reading frames for all viral proteins, while HERV-K101 has a full-length gag open reading frame and is expressed in human male germ cell tumors. The Gag of HERV-K101 allowed production of viral particles and infectivity, although at lower levels than observed with a consensus sequence Gag. Thus, including HERV-K109, at least two HERV-K proviruses in human genome today have functional Gag proteins. In contrast, HERV-K113 Gag supported only very low levels of particle production, and no infectivity was detectable due to a single amino acid substitution (I516M) near the extreme C terminus of the CA protein within Gag. The sequence of this portion of HERV-K CA showed similarities to that of human immunodeficiency virus type 1 and other primate immunodeficiency viruses. The extreme C terminus of CA may be a general determinant of retrovirus particle production. In addition, precise mapping of the defects in HERV-K proviruses as was done here identifies the key polymorphisms that need to be analyzed to assess the possible existence of infectious HERV-K alleles within the human population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004950      PMCID: PMC2612375          DOI: 10.1128/JVI.01439-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Virus-like particles in placentas from normal individuals and patients with systemic lupus erythematosus.

Authors:  E R Dirksen; J A Levy
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

2.  Brief communication: C-type particles in normal human placentas.

Authors:  S S Kalter; R J Helmke; R L Heberling; M Panigel; A K Fowler; J E Strickland; A Hellman
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

3.  Relationships between gene trees and species trees.

Authors:  P Pamilo; M Nei
Journal:  Mol Biol Evol       Date:  1988-09       Impact factor: 16.240

4.  Induction of retrovirus particles in human testicular tumor (Tera-1) cell cultures: an electron microscopic study.

Authors:  D L Bronson; E E Fraley; J Fogh; S S Kalter
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

5.  Insertional polymorphisms of full-length endogenous retroviruses in humans.

Authors:  G Turner; M Barbulescu; M Su; M I Jensen-Seaman; K K Kidd; J Lenz
Journal:  Curr Biol       Date:  2001-10-02       Impact factor: 10.834

6.  Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome.

Authors:  M Ono; T Yasunaga; T Miyata; H Ushikubo
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Authors:  Daniel Melamed; Michal Mark-Danieli; Michal Kenan-Eichler; Osnat Kraus; Asher Castiel; Nihay Laham; Tal Pupko; Fabian Glaser; Nir Ben-Tal; Eran Bacharach
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Susceptibility to two strains of Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  Science       Date:  1967-01-27       Impact factor: 47.728

9.  Late viral interference induced by transdominant Gag of an endogenous retrovirus.

Authors:  Manuela Mura; Pablo Murcia; Marco Caporale; Thomas E Spencer; Kunio Nagashima; Alan Rein; Massimo Palmarini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus.

Authors:  L E Henderson; R Sowder; G Smythers; R E Benveniste; S Oroszlan
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  13 in total

Review 1.  An alternative approach to medical genetics based on modern evolutionary biology. Part 2: retroviral symbiosis.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-08       Impact factor: 5.344

2.  HERV-K HML-2 diversity among humans.

Authors:  Jack Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-08       Impact factor: 11.205

3.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

4.  Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.

Authors:  Kirsten Hanke; Philipp Kramer; Sandra Seeher; Nadine Beimforde; Reinhard Kurth; Norbert Bannert
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

5.  Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.

Authors:  Ming Li; Laszlo Radvanyi; Bingnan Yin; Kiera Rycaj; Jia Li; Raghavender Chivukula; Kevin Lin; Yue Lu; JianJun Shen; David Z Chang; Donghui Li; Gary L Johanning; Feng Wang-Johanning
Journal:  Clin Cancer Res       Date:  2017-07-05       Impact factor: 12.531

6.  Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.

Authors:  Kazuaki Monde; Rafael Contreras-Galindo; Mark H Kaplan; David M Markovitz; Akira Ono
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

7.  Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.

Authors:  Aashish R Jha; Douglas F Nixon; Michael G Rosenberg; Jeffrey N Martin; Steven G Deeks; Richard R Hudson; Keith E Garrison; Satish K Pillai
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

8.  Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.

Authors:  Maja George; Torsten Schwecke; Nadine Beimforde; Oliver Hohn; Claudia Chudak; Anja Zimmermann; Reinhard Kurth; Dieter Naumann; Norbert Bannert
Journal:  Retrovirology       Date:  2011-05-09       Impact factor: 4.602

9.  Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines.

Authors:  Lorenzo Agoni; Jack Lenz; Chandan Guha
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines.

Authors:  Lorenzo Agoni; Chandan Guha; Jack Lenz
Journal:  Front Oncol       Date:  2013-07-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.